Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin versus Vancomycin for catheter infection in hemodialysis patients
IRCT138903234144N2Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- May 2009
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of teicoplanin and vancomycin in catheter-associated bloodstream infection (CRBSI) (2 arms), sponsored by Semnan University of Medical Sciences. Started May 2009; status: completed.
02
Drugs
teicoplaninvancomycin
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on IRCT138903234144N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138903234144N2.